Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$21.32 - $34.81 $27,929 - $45,601
-1,310 Reduced 0.14%
928,596 $27.2 Million
Q4 2023

Feb 14, 2024

SELL
$19.97 - $24.53 $2,895 - $3,556
-145 Reduced 0.02%
929,906 $20.7 Million
Q2 2023

Aug 14, 2023

SELL
$21.38 - $29.19 $795,336 - $1.09 Million
-37,200 Reduced 3.85%
930,051 $26.3 Million
Q1 2023

May 15, 2023

SELL
$21.74 - $30.93 $257,879 - $366,891
-11,862 Reduced 1.21%
967,251 $22.2 Million
Q4 2022

Feb 14, 2023

SELL
$24.81 - $31.52 $256,684 - $326,105
-10,346 Reduced 1.05%
979,113 $27.5 Million
Q3 2022

Nov 14, 2022

BUY
$19.51 - $34.14 $19.3 Million - $33.8 Million
989,459 New
989,459 $28 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.86B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.